TrumpRx started in February with 43 brand-name drugs and has grown to hundreds of listings, most of them generics. The prices on the site are real numbers, but they are cash prices, and for many people the better deal is somewhere else: a copay, a generic at a different pharmacy, a manufacturer assistance program. When we matched the launch list against the independent comparisons published since, we found the answer depends less on the site than on three questions: how you pay, which exact drug and strength you need, and whether a generic exists. This guide gives you the full launch list with prices, the fine print the headlines left out, and a way to check your own prescription in ten minutes.
Key Answers Before You Pay
Nine questions that come up before almost every purchase through a discount site, answered first. The sections after this show the reasoning and the fine print.
It is a federal-government-linked website, launched February 5, that lists cash prices on brand-name drugs from manufacturers with pricing agreements, plus several hundred generics through Cost Plus Drugs, GoodRx and Amazon Pharmacy. The Congressional Research Service says it is not itself a direct-to-consumer platform: it points you to a maker, a coupon or a pharmacy.
It started with 43 brand-name drugs, passed 80 by late April, then added about 600 generics in May and 160 more in June, which Wikipedia’s summary puts at over 800. The count moves, so use the site’s search for the exact drug, strength and quantity you need.
Usually not. TrumpRx lists cash prices, and reporting at launch said purchases do not count toward a deductible. Most insured patients pay less through the plan. A University of Washington example found a senior with two drugs paying about $840 a year in copays versus about $4,068 at the listed cash prices.
People who are uninsured, or paying cash for drugs their plan does not cover, such as weight-loss medicines and fertility drugs. People in a high-deductible plan who have not yet met the deductible may also find a lower cash price, with the catch that it will not build toward the deductible.
Sometimes, and not always. STAT found at least 18 brand-name drugs on the launch list had cheaper generics through GoodRx or Cost Plus, including a $200 heartburn drug with a generic near $6. It also found cases where TrumpRx was lowest, such as the fertility drug Cetrotide at $22.50.
The site lists Wegovy pill $149, Wegovy pen $199, Ozempic $199 and Zepbound $299 as its lowest presidential deals. Earlier reporting said Wegovy’s $199 applied to the first two months before rising, and that Zepbound’s price depended on vial strength. Confirm the dose and the ongoing price before you start.
Federal anti-kickback rules limit the use of coupons with federal programs, and HHS’s inspector general issued guidance on direct-to-consumer sales to enrollees in January. Separately, the White House said a $50-a-month GLP-1 option for seniors began in July. Check with your plan and the program before paying cash.
No independent verification has been published that we could find. The figure appears on the site and in a White House fact sheet, and HHS’s reply to a senator did not explain how savings are calculated. A March New York Times analysis found price cuts on several drugs but generally no match for prices abroad.
Compare four numbers for the same drug, strength and quantity: your insurance copay, the TrumpRx price, a GoodRx coupon, and Cost Plus or Amazon Pharmacy for generics. Then ask your pharmacist whether the pharmacy accepts the coupon and whether a generic is right for you.
What TrumpRx Is and How It Works
Start with what the Congressional Research Service says in its July 31 summary, because it is the most careful description of what the site is. TrumpRx is a website that lists discounts on brand-name and generic drugs through manufacturer partnerships and direct-to-consumer pharmacies. The report is explicit that it is not itself a direct-to-consumer platform. A placeholder site went live in the fall without any drugs, and the official launch was February 5. It was announced in September with Pfizer as the first participant, and its legal footing is an executive order signed May 12 of last year directing the Health and Human Services secretary to facilitate direct-to-consumer programs for manufacturers who sell at a “most-favored-nation” price.
The site is designed and operated by the National Design Studio, a temporary government organization created by an executive order in August of last year. It is integrated with GoodRx, an existing coupon aggregator, and in May it added Cost Plus Drugs and Amazon Pharmacy to bring in about 600 generics. As of May 5, according to the CRS, 17 manufacturers had agreements. A White House fact sheet on August 31 announced nine more agreements and said the total reached 26 manufacturers covering 89% of the branded drug market, though it did not say which of those companies’ drugs would be added to the site.
Two kinds of deals, two kinds of labels
The CRS describes brand-name drugs marketed as “Presidential Deals” and many generics as “Standard Deals.” For some drugs the site routes you to a manufacturer’s own pharmacy partner, as with Mayzent. For others it offers a coupon to print or download for use at participating specialty pharmacies, as with Cetrotide. The site also displays international price comparisons, though the CRS says it is unclear how those are determined. And prices vary by formulation, strength and quantity, which is the single most important sentence for a shopper.
What was said about insurance
The report does not directly say whether purchases count toward a deductible or an out-of-pocket maximum. It points out that copay accumulator programs, increasingly common in private plans, exclude manufacturer assistance from counting toward those limits, and that the site itself says copays may be lower than listed prices. CBS reported at launch that purchases do not count toward an insurance deductible and that a proposal to change that, called the Great Healthcare Plan, had been introduced in January but is not law. Savings, the CRS says, are most likely for uninsured patients or those who go outside their coverage, for example when a drug is not on a formulary.
Reported counts of drugs on the site. March is “more than 50” and the June figure is “over 800” per the sources, so the bars are floors, not exact totals. The jump comes from about 600 generics added in May and 160 more in June, not from new brand-name deals.
| Question | What the sources say | Why it matters |
|---|---|---|
| Is it insurance? | No. It lists cash prices and is not a plan | Nothing here pays a claim |
| Does the purchase count toward my deductible? | At launch, reporting said no; the proposal to change it has not become law | A cheap cash fill does not move you toward your out-of-pocket maximum |
| Can I use insurance at the same time? | The site does not bill insurers; a plan may still be cheaper | Compare the copay first |
| Who runs it? | National Design Studio designs and operates it, per the CRS | It is a government-linked listing, not a pharmacy |
| Does it sell the drug? | At launch it displayed prices and sent users to the maker, a coupon or a pharmacy | You still need a valid prescription and a pharmacy |
| Will the prices last? | The CMS administrator said the agreements run to the end of the current term | Do not plan a five-year budget around today’s price |
| Does it collect my health data? | HHS says it requires no account and does not store patient, health or prescription information | Partner sites you click through to have their own privacy terms |
Pick your lane by how you pay today. Then price the exact drug, strength and quantity in more than one place.
The Medication List and Launch Prices
Here is the launch list in full, grouped by what the drugs treat so you can find yours. The prices are the amounts CBS News listed when the site opened on February 5 and 6, and they are monthly or per-unit cash prices that depend on strength and quantity. They may have changed, and the site now carries many more drugs. We added a column of notes drawn from STAT’s February comparison with generic prices on Cost Plus Drugs and GoodRx. Where STAT found a generic cheaper, the note says by roughly how much; where it found no generic, it says so. When we lined the list up this way, one thing stood out: the drugs with the biggest sticker prices are mostly the ones with no generic, and the drugs with the biggest gaps to a generic are mostly older brands that most people would never need to buy at brand price.
Treat the table as a map, not a quote. The right use is to find your drug, note the strength, and then check the live site and two other sources before you decide.
Diabetes, weight loss and insulin
| Drug | Launch price | Used for | What to check |
|---|---|---|---|
| Ozempic pen | $199 | Diabetes, weight loss | Introductory vs ongoing price; strength |
| Wegovy pen | $199 | Weight loss | Reported to rise after the first two months; confirm |
| Wegovy pill | $149 | Weight loss | Starting dose price; confirm higher doses |
| Zepbound | $299 | Weight loss, sleep apnea | Price depends on vial strength and quantity |
| Farxiga | $181.59 | Diabetes, heart and kidney | Insured copays can be far lower |
| Xigduo XR | $181.59 | Diabetes | STAT lists a small generic gap |
| Insulin lispro | $25 | High blood sugar | Compare with plan copay and Medicare insulin cap |
Fertility and women’s health
| Drug | Launch price | Used for | What to check |
|---|---|---|---|
| Cetrotide | $22.50 | IVF | STAT: the lowest price of three it compared |
| Gonal-F | $168 | Fertility | Strength and pen size change the price a lot |
| Ovidrel | $84 | Fertility | One patient reported paying less at a specialty pharmacy |
| Duavee | $30.30 | Menopause symptoms | No generic per STAT |
| Estring | $249 | Vaginal estrogen ring | No generic per STAT |
| Premarin | $99 | Menopause | STAT lists a small generic gap |
| Premarin vaginal cream | $236.65 | Menopause | STAT lists a small generic gap |
| Prempro | $98.84 | Menopause | No generic per STAT |
Heart, cholesterol, stomach and breathing
| Drug | Launch price | Used for | What to check |
|---|---|---|---|
| Colestid | $127.91 | Cholesterol | STAT: generic could save about $100 |
| Lopid | $39.60 | Cholesterol | Ask about generic gemfibrozil |
| Tikosyn | $336 | Heart rhythm | STAT: large potential generic savings |
| Protonix | $200.10 | Heartburn, acid reflux | Generic reported near $6 at Cost Plus |
| Toviaz | $43.50 | Overactive bladder | STAT lists a small generic gap |
| Airsupra | $201 | Asthma rescue inhaler | No generic per STAT |
| Bevespi | $51 | COPD | Routed to a manufacturer assistance program |
Thyroid, hormones and steroids
| Drug | Launch price | Used for | What to check |
|---|---|---|---|
| Cytomel | $6 | Thyroid | Generic gap about $2.64 per STAT |
| Levoxyl | $35.10 | Underactive thyroid | Generic levothyroxine is widely available |
| Cortef | $45 | Inflammation, adrenal | STAT: generic about $38 less |
| Medrol | $3.15 | Inflammation | Already low; generic gap small |
| Genotropin | $89.67 | Growth hormone | No generic per STAT |
| Ngenla | $2,217 | Growth hormone | No generic per STAT |
Mental health, brain, migraine and quitting smoking
| Drug | Launch price | Used for | What to check |
|---|---|---|---|
| Pristiq | $200.10 | Depression | STAT: generic about $186 less |
| Zarontin | $71.10 | Seizures | STAT: generic about $38 less |
| Zavzpret | $594.84 | Migraine | No generic per STAT |
| Chantix | $106.20 | Quit smoking | STAT: generic about $79 less |
| Nicotrol | $271.16 | Quit smoking | No generic per STAT |
Autoimmune, infection and skin
| Drug | Launch price | Used for | What to check |
|---|---|---|---|
| Abrilada pen | $207.60 | Autoimmune | STAT lists no change |
| Azulfidine tablets | $99.60 | Rheumatology, bowel disease | STAT: generic about $147 less |
| Azulfidine EN tablets | $130.80 | Rheumatology | STAT: generic about $246 less |
| Xeljanz | $1,518 | Rheumatoid arthritis | No generic per STAT |
| Eucrisa | $158.48 | Eczema | No generic per STAT |
| Cleocin | $94.35 | Antibiotic | Generic comes in a different form |
| Diflucan | $14.06 | Antifungal | Generic gap about $2.64 per STAT |
| Vfend | $306.98 | Antifungal | STAT: generic about $70 less |
| Viracept | $607.20 | HIV | No generic per STAT |
| Zyvox | $122.74 | Antibiotic | Generic comes in a different form |
Where a Better Deal May Already Exist
The clearest independent look at the launch list came from STAT on February 6. It analyzed the 43 listings, classified how each discount is delivered, and compared them with generic prices on Cost Plus Drugs and GoodRx. It found that 34 of the 43 drugs reach you through third-party discount cards or coupons, with a discount indistinguishable from what GoodRx presents. Five were manufacturer direct programs and four were partnerships between a manufacturer and a pharmacy. About half of the launch drugs have generics, and at least 18 had a cheaper generic available through GoodRx or Cost Plus. Pfizer alone had 31 drugs on the site, and at least 17 of them had cheaper generics.
The examples are vivid. Protonix, a heartburn drug, was listed at $200.10 for a 30-pack, while a generic with the same dosage and count cost about $6 at Cost Plus Drugs. The reverse also happened. Cetrotide, a fertility drug, was $22.50 on the site, $49.50 as a generic at Cost Plus and $309 at GoodRx. KFF’s analysis, as cited in a March ClearHealthCosts piece, found at least 17 of the 22 TrumpRx drugs with U.S. generics cost less through GoodRx or Cost Plus, while five brand-name drugs were cheaper on TrumpRx than generics elsewhere.
Why a brand price can be the wrong comparison
Brian Reid of Reid Strategic and Tufts’ Center for the Evaluation of Value and Risk in Health told STAT that direct-to-patient sales have a role, but that promoting brand-name drugs as great deals when generics exist could steer patients away from cheaper options. Mark Cuban said Cost Plus Drugs usually beats the site on brands that have generics, while praising the fertility prices. A White House official said the site focuses on branded products, where it offers the lowest prices. All three statements can be true at once, which is why the useful question is not “is the site good” but “is it best for my drug.”
Prices abroad
The administration frames the program around matching prices in other wealthy countries. A March analysis by the New York Times, as summarized on Wikipedia, found that the site reduced several prices but generally did not beat other wealthy countries, with some prices about twice as high as abroad. A report cited in May noted that German public-insurance prices were lower in more than half of one set of comparisons. These findings are single analyses with their own methods, and the site’s own comparison method is not explained, according to the CRS. They are worth knowing because they tell you not to treat “most favored nation” as a guarantee of the lowest price on your prescription.
How STAT classified the 43 launch listings. Its finding: for the 34 coupon-based drugs, the discount is indistinguishable from what GoodRx presents. Red = coupon routes.
Both directions are real. STAT’s February analysis found a $200 brand-name heartburn drug on the site beside a generic costing about $6, and a fertility drug where the site’s $22.50 was the lowest of the three prices it compared. Compare the exact drug, strength and quantity before you assume either answer.
Find Your Situation
A list price does not pay your bill. These are the moments that decide what you spend, and what tends to work in each.
The most common mistake is assuming a government-linked discount site beats a plan. For many insured people it does not. The site lists cash prices, it does not bill your insurer, and at launch reporting was clear that those purchases do not count toward a deductible or out-of-pocket maximum. The University of Washington authors of a STAT opinion piece gave a concrete case: two drugs at about a $35 copay each is roughly $840 a year, versus about $4,068 a year at the listed cash prices.
So the first call is to your pharmacy or plan: what is my copay for this exact drug? If the copay is lower, use it. The one wrinkle is a drug your plan does not cover or a prior authorization that keeps getting denied, where a lower cash price could be the practical route. Even then, ask your doctor first about a covered alternative.
Uninsured patients are the group that analysts on both sides of the debate agree could benefit most, and the roughly 15% of Americans without good prescription coverage are the audience the site is built for, according to the University of Washington authors. If your drug is brand-only, with no generic, the TrumpRx price may be the lowest published number. STAT’s comparison counted several drugs, such as Farxiga and Cetrotide, where TrumpRx was lower than the alternatives it checked.
Do not stop at the first price. For the same drug, check the manufacturer’s own patient assistance program, which can be free or nearly free for people with low incomes, then GoodRx, then the site. Several TrumpRx listings simply route you to a manufacturer assistance program or coupon you could have found yourself, so a few minutes of comparison can save real money.
This is the in-between case. Until you meet the deductible you may be paying a plan’s negotiated price in full, which can be higher than a cash coupon. A lower cash price could cost you less today. The trade-off is that the purchase may not count toward your deductible, so you may be paying cash all year without getting closer to the coverage you pay premiums for.
The practical answer is to do the arithmetic for a full year. For a drug you take every month, compare twelve fills at the cash price against twelve fills through the plan, including how the plan’s price changes after the deductible is met. For a one-time or occasional drug, the cash price usually wins. Ask your plan whether it accepts receipts from cash purchases toward the deductible; some will, many will not, and it is worth one phone call.
This is where the site gets the most attention, and where the fine print matters most. At launch the listed prices were Wegovy pen $199, Wegovy pill $149, Ozempic $199 and Zepbound $299, and the White House’s own site pages as we read them show those as the lowest presidential deals against list prices of roughly $1,000 to $1,350. Earlier reporting in March said Wegovy’s $199 applied to the first two months and rose to $349, and that Zepbound’s price matched the manufacturer’s direct-to-patient price at $399 for the 5 mg strength. A May report put Ozempic at $350 a month. These figures conflict because doses, strengths and introductory offers differ.
Before you start, ask three questions: what is the price at my maintenance dose, what is the price after any introductory period, and how does it compare with the manufacturer’s own cash program and with telehealth providers that also list a price. The Council of Economic Advisers estimated up to $3,000 a year in savings per patient by 2028 for people who buy these drugs outside insurance, which is a projection, not a measurement. Also confirm with your prescriber that the drug is right for you.
Federal anti-kickback rules limit coupon and discount use with federal health programs, and the HHS Office of Inspector General issued a Special Advisory Bulletin in January on when direct-to-consumer sales to federal program enrollees can run afoul of them. The Congressional Research Service notes that HHS also asked the public whether rules need to change. In short: do not assume a coupon site is available to you. Ask your plan, or call 1-800-MEDICARE.
Separately from the site, the White House said a $50-a-month GLP-1 option for seniors began in July. That is a Medicare matter, not a TrumpRx purchase. Check how it works with your Part D plan. Medicare Part D has an annual out-of-pocket cap and a $35 monthly insulin cap under the Inflation Reduction Act, so insured seniors often pay far less than a cash price. Compare your plan’s price for your drugs, including on Medicare’s plan finder, before paying cash.
Roughly nine in ten U.S. prescriptions are for generics, which is why the May expansion matters more to most households than the original 43-drug list. About 600 generics were added in May with Cost Plus Drugs, GoodRx and Amazon Pharmacy, with many priced under $5 and a tool that points you to the lowest-priced pharmacy nearby or a home-delivery option. A further 160 were added in June.
If you take lisinopril, metformin, atorvastatin or a similar everyday drug, check each of those three sources. Prices on a coupon site swing by pharmacy, so look at the map and compare the pharmacy you would actually use. Ask the pharmacist whether they accept the coupon, since some pharmacies reject certain discount cards. And never switch brands, doses or drugs on your own because a price looks lower; ask the prescriber.
The Council of Economic Advisers estimated about $2,191 per in vitro fertilization cycle in savings, and the site’s launch list included Cetrotide at $22.50, Ovidrel at $84 and Gonal-F at $168. STAT’s comparison found Cetrotide was cheaper on TrumpRx than the other prices it checked, including $309 at GoodRx and $49.50 for a generic at Cost Plus. A separate review noted one patient reporting $58 per Ovidrel injection at a specialty pharmacy against the site’s $84.
The lesson is that fertility drugs are priced by strength, pen size and pharmacy, so your clinic’s recommended product matters more than the headline. Ask your clinic to write the exact products and strengths, then price each at the site, at your specialty pharmacy and at a coupon site. Keep receipts, since some employers and flexible-spending accounts reimburse eligible costs.
The University of Washington authors raised a point that often gets lost in price talk. When you buy through several channels, no single pharmacist sees your full list, which raises the risk of interactions, duplicate therapies and dosing errors. For an older adult on many drugs, that safety net is worth money.
If you use cash channels for one or two drugs, tell your main pharmacist and your prescriber what you are taking and where you got it. Keep one updated medication list in your wallet or phone. A pharmacist can run an interaction check on anything you tell them about.
A government-linked list can send you to a manufacturer, a pharmacy or a coupon, and you should still confirm each destination is a licensed pharmacy that requires a prescription. Counterfeit and unapproved drugs are sold through websites that look professional. The FDA’s BeSafeRx campaign and the National Association of Boards of Pharmacy’s safe.pharmacy listing are the places to verify a pharmacy.
Be wary of any site that offers prescription drugs without a prescription, sells at prices far below every other listing, or has no pharmacist you can reach. HHS says TrumpRx requires no account and does not store patient, health or prescription information, but the sites you click through to have their own privacy practices, so read them.
The honest answer is that evidence is limited, and that both sides have a case. The White House says TrumpRx offers the lowest prices on branded drugs and that patients have saved more than $700 million; HHS’s reply to a senator did not explain how savings are calculated. Critics point to how many launch listings were already available through GoodRx or manufacturer programs, which STAT classified at 34 of 43, and to generics that cost less. A March New York Times analysis found price cuts on several drugs but generally not parity with prices abroad, with some TrumpRx prices about twice as high.
What we can say from reading the primary documents is narrower. The site is real, it is government-linked, and its list is growing. For some patients it is the lowest price, and for many it is not. The agreements behind the brand-name prices were described by the CMS administrator as running to the end of the current presidential term, so durability is unproven. The practical rule is the same either way: price your own drug in more than one place.
Mistakes that cost money or health
Assuming a brand price is the lowest because it is government-listed. The launch list had at least 18 brand drugs with cheaper generics elsewhere.
Comparing different strengths or quantities. A price for 30 tablets and a price for 90 are not comparable, and neither is a starting dose and a maintenance dose.
Paying cash when the plan copay is lower. Insured patients usually pay less through the plan, and cash fills do not build toward a deductible.
Not asking about the price after the introductory period. Some weight-loss prices reportedly rise after two months.
Using a coupon with a federal program without checking the rules. Medicare and Medicaid enrollees face restrictions.
Buying from a site that does not require a prescription. A real pharmacy does, and verification tools exist.
Switching drugs on your own to chase a lower price. A cheaper medicine that is wrong for you is not a saving. Talk to your prescriber first.
Weight-Loss and Diabetes Drugs: The Fine Print
Weight-loss and diabetes drugs are the reason many people first visited the site, so they get their own section. As the site reads now, it shows Wegovy pill at $149 a month, Wegovy pen at $199, Ozempic at $199 and Zepbound at $299, each described as a lowest presidential deal against list prices of roughly $1,028 to $1,349. Those are the headline numbers, and several details sit behind them.
In March, ClearHealthCosts reported that Wegovy’s $199 applied only to the first two months before rising to $349, while Ro and GoodRx listed $149 a month at that time. It also reported that Zepbound’s self-pay price on the site matched LillyDirect’s at $399 for the 5 mg strength, four vials. A May report put Ozempic at $350 a month. The conflicts are not necessarily errors. They reflect that these drugs come in several doses and that introductory offers differ from maintenance prices. When we compared these reports side by side, we found no single number you can rely on without checking your dose.
Questions to ask before you start
What is the price at my maintenance dose? What does the price become after any introductory period? Is the same drug available at a lower cash price through the manufacturer or a telehealth service? Does my plan or an employer program cover it, even partly? And is a GLP-1 appropriate for me according to my prescriber? The Council of Economic Advisers estimated up to $3,000 per patient per year by 2028 in savings for people who use these drugs outside coverage, but that is a projection.
The Medicare side
On May 1, the president said GLP-1 drugs would be available to Medicare patients for $50 a month starting July 1, and a White House fact sheet later said that $50 access for seniors began in July. That is a Medicare program, not a purchase through the website, and details such as eligibility and which drugs are covered come from the program, not from this page. If you are on Medicare, ask your Part D plan how it works for you.
Check Your Own Price in Ten Minutes
Ten minutes is enough to price a prescription properly. Do it in this order, and write each number down with the strength and quantity beside it.
Step one: get the exact prescription details
Write down the drug name, the strength, the quantity and how often you take it. Whether a drug is a brand or a generic changes the price more than anything else, so ask your pharmacist whether a generic version exists for your exact drug and dose. If it does, the question for your prescriber is whether it is appropriate for you.
Step two: your insurance price
Call your pharmacy or plan and ask for the copay for that exact fill. If you are in a high-deductible plan, ask what you would pay before and after the deductible is met.
Step three: three cash prices
Check the TrumpRx page, a GoodRx coupon price for your zip code, and Cost Plus Drugs or Amazon Pharmacy for generics. Use the pharmacy map on the site for local prices. Compare the same strength and quantity, and note whether a price is introductory.
Step four: help programs
Search the drug’s manufacturer name plus “patient assistance.” Nonprofit directories such as NeedyMeds list programs. Some TrumpRx listings route you to exactly these programs, but others do not, and eligibility often depends on income. Federal and state programs matter too: if you may qualify for Medicaid or an insurance subsidy, a cash price is not your only choice.
Step five: confirm before you pay
Ask the pharmacy whether it accepts the coupon or price, and whether it will count it toward anything on your plan. Confirm a licensed pharmacy is filling the prescription. Keep the receipt. If a price differs at the counter, ask the pharmacist to run the coupon again or to show you the quoted price on your phone.
Help, Contacts and Next Steps
Use the official site for the current list, then compare it with at least two other sources. If you have a question about your Medicare drug coverage, call 1-800-MEDICARE or your state’s health insurance counseling program. To confirm that an online pharmacy is licensed, use the FDA’s BeSafeRx page or the pharmacy boards’ safe.pharmacy listing. For help paying, search patient assistance programs by drug name.
Prices, counts and policies come from the site, Congressional Research Service and White House documents, HHS correspondence and published reporting and analyses reviewed in mid-October. Launch prices are those reported at the February launch and may have changed; the site’s current prices, drug count and terms may differ, and sources sometimes conflicted, in which case this page gives a range or names the source. Savings and “most-favored-nation” claims are as stated by the parties and have not been independently verified here. This page is independent editorial content, is not affiliated with the federal government, and is not medical, legal or financial advice. Ask your prescriber and pharmacist before changing any medicine.
Key sources: trumprx.gov · Congressional Research Service In Focus IF13281 · White House fact sheets · HHS letter to Sen. Warren · CBS News launch list · STAT analysis · KFF analysis as cited · Becker’s Hospital Review · University of Washington authors’ STAT commentary · Medicare.gov.